A Laura Nijstad

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Favipiravir is a novel antiviral drug approved for influenza treatment in Japan. Little is known about favipiravir pharmacokinetics in critically ill patients. Here, we report a patient with influenza treated with favipiravir and undergoing continuous venovenous hemofiltration (CVVH) on the Intensive Care Unit of a tertiary hospital in the Netherlands.(More)
  • 1